Follow The Filings

JANX Janux Therapeutics

Janux Therapeutics earnings company data as of 4:47 AM ET 10/24

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 5 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by JANX's executives, directors and 10% owners in the last 12 months, from their Form 4s

All JANX insider trades
  • None no insider bought on the open market
  • $29K sold by 1 insider outside a trading plan
  • $711K sold by 1 insider under 10b5-1 plans
  1. Maria Dobek Vice President, Accounting
    Sale
    $29K 2,038 shares at $14.17 5.9% of stake
    Traded May 11 Filed May 13
    ↗
  2. Andrew Hollman Meyer Chief Business Officer
    Planned sale
    $110K 3,333 shares at $32.98 3.8% of stake
    Traded Dec 1, 2025 Filed Dec 3, 2025
    ↗
  3. Andrew Hollman Meyer Chief Business Officer
    Planned sale
    $100K 3,333 shares at $30.00 3.8% of stake
    Traded Nov 14, 2025 Filed Nov 14, 2025
    ↗
  4. Andrew Hollman Meyer Chief Business Officer
    Planned sale
    $501K 16,665 shares at $30.06 17% of stake
    Traded Oct 28, 2025 Filed Oct 30, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 14 stock grants, 7 sales to cover taxes, 5 option exercises, and 1 gift.

SEC filings

Recent issuer filings from EDGAR, 24 shown.

Filed Form Detail Links
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 8.01 Filing Doc
8-K 5.07 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G — Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
8-K 5.02 Filing Doc
8-K 2.02,9.01 Filing Doc
10-K Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G — Filing Doc
8-K 1.01,7.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc

Source: SEC EDGAR submissions, updated 6 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.